Cargando…

Clinic-Based Urinary Lipoarabinomannan as a Biomarker of Clinical Disease Severity and Mortality Among Antiretroviral Therapy-Naive Human Immunodeficiency Virus-Infected Adults in South Africa

BACKGROUND: Urinary lipoarabinomannan (LAM) has limited sensitivity for diagnosing active human immunodeficiency virus (HIV)-associated tuberculosis (TB) disease, but LAM screening at HIV diagnosis might identify adults with more severe clinical disease or greater risk of mortality. METHODS: We enro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drain, Paul K., Losina, Elena, Coleman, Sharon M, Giddy, Janet, Ross, Douglas, Katz, Jeffrey N, Freedberg, Kenneth A, Bassett, Ingrid V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622366/ https://www.ncbi.nlm.nih.gov/pubmed/28979922 http://dx.doi.org/10.1093/ofid/ofx167

Ejemplares similares

Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis
por: Drain, Paul K., et al.
Publicado: (2016)

The Linkage Outcomes of a Large-scale, Rapid Transfer of HIV-infected Patients From Hospital-based to Community-based Clinics in South Africa
por: Cloete, Christie, et al.
Publicado: (2014)

Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed hiv-infected adults: a prospective, clinic-based study
por: Drain, Paul K, et al.
Publicado: (2014)

Risk Factors for Late-Stage HIV Disease Presentation at Initial HIV Diagnosis in Durban, South Africa
por: Drain, Paul K., et al.
Publicado: (2013)

Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu‐Natal
por: Drain, PK, et al.
Publicado: (2015)

Drug-Resistant Tuberculosis among HIV-Infected Patients Starting Antiretroviral Therapy in Durban, South Africa
por: Hom, Jeffrey K., et al.
Publicado: (2012)

Factors Associated with Self-Reported Repeat HIV Testing after a Negative Result in Durban, South Africa
por: Regan, Susan, et al.
Publicado: (2013)

Diagnostic Accuracy of a Novel and Rapid Lipoarabinomannan Test for Diagnosing Tuberculosis Among People With Human Immunodeficiency Virus
por: Bjerrum, Stephanie, et al.
Publicado: (2019)

A randomized trial to optimize HIV/TB care in South Africa: design of the Sizanani trial
por: Bassett, Ingrid V, et al.
Publicado: (2013)

The Survival Benefits of Antiretroviral Therapy in South Africa
por: April, Michael D., et al.
Publicado: (2014)

Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South Africa
por: Bassett, Ingrid V., et al.
Publicado: (2016)

Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South Africa
por: Bassett, Ingrid V., et al.
Publicado: (2017)

Using national laboratory data to assess cumulative frequency of linkage after transfer to community‐based HIV clinics in South Africa
por: Bassett, Ingrid V, et al.
Publicado: (2019)

Plasma Profiles of Inflammatory Markers Associated With Active Tuberculosis in Antiretroviral Therapy-Naive Human Immunodeficiency Virus-Positive Individuals
por: Olsson, Oskar, et al.
Publicado: (2019)

Lateral Flow Urine Lipoarabinomannan Assay for Diagnosis of Active Tuberculosis in Adults With Human Immunodeficiency Virus Infection: A Prospective Cohort Study
por: Songkhla, Munjit Na, et al.
Publicado: (2019)

Clinical and Mucosal Immune Correlates of HIV-1 Semen Levels in Antiretroviral-Naive Men
por: Osborne, Brendan J. W., et al.
Publicado: (2017)

Routine HIV Testing in Adolescents and Young Adults Presenting to an Outpatient Clinic in Durban, South Africa
por: Ramirez-Avila, Lynn, et al.
Publicado: (2012)

Subclinical tuberculosis among adults with HIV: clinical features and outcomes in a South African cohort
por: Bajema, Kristina L., et al.
Publicado: (2019)

Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus
por: Desmonde, Sophie, et al.
Publicado: (2019)

The “ART” of Linkage: Pre-Treatment Loss to Care after HIV Diagnosis at Two PEPFAR Sites in Durban, South Africa
por: Losina, Elena, et al.
Publicado: (2010)

Projected Benefits of Long-Acting Antiretroviral Therapy in Nonsuppressed People With Human Immunodeficiency Virus Experiencing Adherence Barriers
por: Chen, Wanyi, et al.
Publicado: (2023)

Standardized Urine-Based Tuberculosis (TB) Screening With TB-Lipoarabinomannan and Xpert MTB/RIF Ultra in Ugandan Adults With Advanced Human Immunodeficiency Virus Disease and Suspected Meningitis
por: Cresswell, Fiona V, et al.
Publicado: (2020)

Income Inequality Is Associated With Low Cumulative Antiretroviral Adherence in Persons With Human Immunodeficiency Virus
por: Vernon, Frances, et al.
Publicado: (2020)

Prevalence and Outcomes of Hepatitis B Coinfection and Associated Liver Disease Among Antiretroviral Therapy-Naive Individuals in a Rural Tanzanian Human Immunodeficiency Virus Cohort
por: Ramírez-Mena, Adrià, et al.
Publicado: (2016)

Beyond Undetectable: Modeling the Clinical Benefit of Improved Antiretroviral Adherence in Persons With Human Immunodeficiency Virus With Virologic Suppression
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2023)

Myocardial Fibrosis Among Antiretroviral Therapy-Treated Persons With Human Immunodeficiency Virus in South Africa
por: Shuldiner, Scott R, et al.
Publicado: (2020)

First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic
por: Christopoulos, Katerina A, et al.
Publicado: (2022)

Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study
por: Drain, Paul K, et al.
Publicado: (2015)

Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa
por: Paltiel, A. David, et al.
Publicado: (2017)

The Effect of Rosuvastatin on Markers of Immune Activation in Treatment-Naive Human Immunodeficiency Virus-Patients
por: Weijma, Robyn G. M., et al.
Publicado: (2015)

Short-term Mortality Outcomes of HIV-Associated Cryptococcal Meningitis in Antiretroviral Therapy–Naïve and –Experienced Patients in Sub-Saharan Africa
por: Kalata, Newton, et al.
Publicado: (2021)

Cost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency Virus
por: Reddy, Krishna P, et al.
Publicado: (2020)

Antiretroviral Refill Histories as a Predictor of Future Human Immunodeficiency Virus Viremia
por: Sokpa, Darryl, et al.
Publicado: (2022)

Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study
por: Henrich, Timothy J., et al.
Publicado: (2014)

Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy
por: Bernal, Silvia, et al.
Publicado: (2023)

Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort
por: Balagopal, Ashwin, et al.
Publicado: (2016)

Factors Associated With Liver Steatosis in People With Human Immunodeficiency Virus on Contemporary Antiretroviral Therapy
por: Riebensahm, Carlotta, et al.
Publicado: (2022)

Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis
por: De Castro, Nathalie, et al.
Publicado: (2022)

A Sensitive Urinary Lipoarabinomannan Test for Tuberculosis
por: Hamasur, Beston, et al.
Publicado: (2015)

Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence
por: Oladele, Rita O., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e7o4gd4shh7qa9rge6q3dbbdmq